This week's Fierce Pharma Marketing is brought to you by AlphaSense.
While there is no shortage of innovation in biotech, there are still major challenges faced by all companies. Within the evolving drug development landscape, it’s no surprise that external innovation through partnerships and acquisitions is a critical part of the biotech ecosystem. We are thrilled to have Dr. Yaron Werber join us to share a behind-the-scenes look at what goes on before and after deals reach the negotiating table.
- An overview of the biggest M&A trends and forecasts in the biotech space
- The ingredients for a successful deal from both the perspective of the acquirer and smaller companies
- How to evaluate when to take a risk, and the different challenges between internal and external innovation.
|
| You are currently subscribed as newsletter@newslettercollector.com |
